CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- 4 Open-market sale Chief Executive Officer sold 9,406 shares at $2.44 ($22,951)
- 4 Open-market sale Chief Data Officer sold 7,089 shares at $2.44 ($17,297)
- 4 Open-market sale General Counsel sold 7,084 shares at $2.44 ($17,285)
- 4 Open-market sale Chief Information Officer sold 6,551 shares at $2.44 ($15,984)
- 4 Open-market sale Chief Scientific Officer sold 5,132 shares at $2.44 ($12,522)
- 4 Open-market sale Chief Financial Officer sold 6,374 shares at $2.44 ($15,553)
- 4 Open-market sale Director sold 107 shares at $3.35 ($358)
- 4 Grant or award Director acquired 30,534 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Information Officer sold 3,874 shares at $4.16 ($16,116)
- 4 Open-market sale Chief Executive Officer sold 29,722 shares at $4.12 ($122,455)
- 4 Open-market sale Chief Financial Officer sold 4,818 shares at $4.12 ($19,850)
- 4 Open-market sale Director sold 99 shares at $4.16 ($412)
- 4 Open-market sale Chief Data Officer sold 1,338 shares at $4.16 ($5,566)
- 4 Open-market sale General Counsel sold 2,285 shares at $4.16 ($9,506)
- 4 Open-market sale Chief Information Officer sold 3,251 shares at $4.16 ($13,524)
- 4 Open-market sale Chief Scientific Officer sold 2,044 shares at $4.16 ($8,503)
- 4 Open-market sale Chief Financial Officer sold 540 shares at $4.16 ($2,246)
- 4 Planned sale Chief Information Officer sold 3,610 shares at $4.28 ($15,451)
- 4 Open-market sale Director sold 101 shares at $4.58 ($463)
Page 7 of 16 · 313 filings